J. Ferlay, I. Soerjomataram, R. Dikshit, S. Eser, C. Mathers et al., Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012, Int J Cancer, vol.136, pp.359-86, 2015.

V. Divi, M. M. Chen, B. Nussenbaum, K. F. Rhoads, D. B. Sirjani et al., Lymph node count from neck dissection predicts mortality in head and neck cancer, J Clin Oncol, 2016.

J. Bernier, C. Domenge, M. Ozsahin, K. Matuszewska, J. L. Lefebvre et al., Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer, N Engl J Med, vol.350, pp.1945-1952, 2004.

S. Warnakulasuriya and A. Ariyawardana, Malignant transformation of oral leukoplakia: a systematic review of observational studies, J Oral Pathol Med, vol.45, pp.155-166, 2016.

I. Balasundaram, K. F. Payne, I. Al-hadad, M. Alibhai, S. Thomas et al., Is there any benefit in surgery for potentially malignant disorders of the oral cavity?, J Oral Pathol Med, vol.43, pp.239-244, 2014.

L. Mao, J. S. Lee, Y. H. Fan, J. Y. Ro, J. G. Batsakis et al., Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment, Nat Med, vol.2, pp.682-685, 1996.

M. P. Rosin, X. Cheng, C. Poh, W. L. Lam, Y. Huang et al., Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia, Clin Cancer Res, vol.6, pp.357-362, 2000.

L. Zhang, C. F. Poh, M. Williams, D. M. Laronde, K. Berean et al., Loss of heterozygosity (LOH) profiles-validated risk predictors for progression to oral cancer, Cancer Prev Res (Phila), vol.5, pp.1081-1089, 2012.

T. Benchekroun, M. Saintigny, P. Thomas, S. M. El-naggar, A. K. Papadimitrakopoulou et al., Epidermal growth factor receptor expression and gene copy number in the risk of oral cancer, Cancer Prev Res (Phila), vol.3, pp.800-809, 2010.

R. J. Leeman-neill, R. R. Seethala, S. V. Singh, M. L. Freilino, J. S. Bednash et al., Inhibition of EGFR-STAT3 signaling with erlotinib prevents carcinogenesis in a chemicallyinduced mouse model of oral squamous cell carcinoma, Cancer Prev Res (Phila), vol.4, pp.230-237, 2011.

J. E. Bauman and J. Grandis, Oral Cancer Chemoprevention-the End of EPOC, the beginning of an epoch of molecular selection, JAMA Oncol, vol.2, pp.178-179, 2016.

V. A. Papadimitrakopoulou, W. N. William, J. Dannenberg, A. J. Lippman, S. M. Lee et al., Pilot randomized phase II study of celecoxib in oral premalignant lesions, Clin Cancer Res, vol.14, pp.2095-2101, 2008.

V. A. Papadimitrakopoulou, J. J. Lee, W. N. William, J. Martin, J. W. Thomas et al., Randomized trial of 13-cis retinoic acid compared with retinyl palmitate with or without beta-carotene in oral premalignancy, J Clin Oncol, vol.27, pp.599-604, 2009.

S. M. Lippman, J. G. Batsakis, B. B. Toth, R. S. Weber, J. J. Lee et al., Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis, N Engl J Med, vol.328, pp.15-20, 1993.

W. N. William, V. Papadimitrakopoulou, J. J. Lee, L. Mao, E. E. Cohen et al., Erlotinib and the risk of oral cancer: the erlotinib prevention of oral cancer (EPOC) randomized clinical trial, JAMA Oncol, vol.2, pp.209-216, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01796193

W. K. Hong, J. Endicott, L. M. Itri, W. Doos, J. G. Batsakis et al., 13-cisretinoic acid in the treatment of oral leukoplakia, N Engl J Med, vol.315, pp.1501-1505, 1986.

W. B. Armstrong, T. H. Taylor, A. R. Kennedy, R. J. Melrose, D. V. Messadi et al., Bowman birk inhibitor concentrate and oral leukoplakia: a randomized phase IIb trial, Cancer Prev Res (Phila), vol.6, pp.410-418, 2013.

V. Walter, X. Yin, M. D. Wilkerson, C. R. Cabanski, N. Zhao et al., Molecular subtypes in head and neck cancer exhibit distinct patterns of chromosomal gain and loss of canonical cancer genes, PLoS One, vol.8, p.56823, 2013.

, Comprehensive genomic characterization of head and neck squamous cell carcinomas, Cancer Genome Atlas N, vol.517, pp.576-582, 2015.

M. K. Keck, Z. Zuo, A. Khattri, T. P. Stricker, C. D. Brown et al., Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes, Clin Cancer Res, vol.21, pp.870-881, 2015.

L. De-cecco, M. Nicolau, M. Giannoccaro, M. G. Daidone, P. Bossi et al., Head and neck cancer subtypes with biological and clinical relevance: meta-analysis of geneexpression data, Oncotarget, vol.6, pp.9627-9642, 2015.

J. P. Foy, L. Bazire, S. Ortiz-cuaran, S. Deneuve, J. Kielbassa et al., A 13-gene expressionbased radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes, BMC Med, vol.15, p.165, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01589514

P. Saintigny, L. Zhang, Y. H. Fan, A. K. El-naggar, V. A. Papadimitrakopoulou et al., Gene expression profiling predicts the development of oral cancer, Cancer Prev Res (Phila), vol.4, pp.218-229, 2011.

A. Subramanian, P. Tamayo, V. K. Mootha, S. Mukherjee, B. L. Ebert et al., Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles, Proc Natl Acad Sci U S A, vol.102, pp.15545-15550, 2005.

D. A. Barbie, P. Tamayo, J. S. Boehm, S. Y. Kim, S. E. Moody et al., Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1, Nature, vol.462, pp.108-112, 2009.

M. Reich, T. Liefeld, J. Gould, J. Lerner, P. Tamayo et al., GenePattern 2.0, Nat Genet, vol.38, pp.500-501, 2006.

E. Becht, N. A. Giraldo, L. Lacroix, B. Buttard, N. Elarouci et al., Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
URL : https://hal.archives-ouvertes.fr/hal-01398093

, Genome Biol, vol.17, p.218, 2016.

P. Saintigny, A. K. El-naggar, V. Papadimitrakopoulou, H. Ren, Y. H. Fan et al., DeltaNp63 overexpression, alone and in combination with other biomarkers, predicts the development of oral cancer in patients with leukoplakia, Clin Cancer Res, vol.15, pp.6284-6291, 2009.

E. Tsitsiou and M. A. Lindsay, microRNAs and the immune response, Curr Opin Pharmacol, vol.9, pp.514-520, 2009.

M. El-gazzar and C. E. Mccall, MicroRNAs regulatory networks in myeloid lineage development and differentiation: regulators of the regulators, Immunol Cell Biol, vol.90, pp.587-593, 2012.

K. Podshivalova and D. R. Salomon, MicroRNA regulation of T-lymphocyte immunity: modulation of molecular networks responsible for T-cell activation, differentiation, and development, Crit Rev Immunol, vol.33, pp.435-476, 2013.

M. P. Rosin, W. L. Lam, C. Poh, N. D. Le, R. J. Li et al., 3p14 and 9p21 loss is a simple tool for predicting second oral malignancy at previously treated oral cancer sites, Cancer Res, vol.62, pp.6447-6450, 2002.

A. Spira, M. B. Yurgelun, L. Alexandrov, A. Rao, R. Bejar et al., Precancer atlas to drive precision prevention trials, Cancer Res, vol.77, pp.1510-1541, 2017.

M. D. Wilkerson, X. Yin, K. A. Hoadley, Y. Liu, M. C. Hayward et al., Lung squamous cell carcinoma mRNA expression subtypes are reproducible, clinically important, and correspond to normal cell types, Clin Cancer Res, vol.16, pp.4864-4875, 2010.

H. Kadara, C. Behrens, P. Yuan, L. Solis, D. Liu et al., A five-gene and corresponding protein signature for stage-I lung adenocarcinoma prognosis, Clin Cancer Res, vol.17, pp.1490-1501, 2011.

M. P. Mak, P. Tong, L. Diao, R. J. Cardnell, D. L. Gibbons et al., A patient-derived, pan-cancer emt signature identifies global molecular alterations and immune target enrichment following epithelial-to-mesenchymal transition, Clin Cancer Res, vol.22, pp.609-620, 2016.

S. V. Puram, I. Tirosh, A. S. Parikh, A. P. Patel, K. Yizhak et al., Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer, Cell, vol.171, pp.1611-1635, 2017.

V. Thorsson, D. L. Gibbs, S. D. Brown, D. Wolf, D. S. Bortone et al., The immune landscape of cancer. Immunity, vol.48, pp.812-842, 2018.

N. K. Cervigne, P. P. Reis, J. Machado, B. Sadikovic, G. Bradley et al., Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma, Hum Mol Genet, vol.18, pp.4818-4829, 2009.

S. Su, Q. Zhao, C. He, D. Huang, J. Liu et al., miR-142-5p and miR-130a-3p are regulated by IL-4 and IL-13 and control profibrogenic macrophage program, Nat Commun, vol.6, p.8523, 2015.

S. Xu, J. Wei, F. Wang, K. Ly, L. Xy et al., Effect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastoma, J Natl Cancer Inst, issue.8, p.106, 2014.

A. Spira, M. L. Disis, J. T. Schiller, E. Vilar, T. R. Rebbeck et al., Leveraging premalignant biology for immune-based cancer prevention, Proc Natl Acad Sci U S A, vol.113, pp.10750-10758, 2016.

R. L. Ferris, G. Blumenschein, J. Fayette, J. Guigay, J. Colevas et al., Nivolumab for recurrent squamous-cell carcinoma of the head and neck, N Engl J Med, 2016.

L. Q. Chow, R. Haddad, S. Gupta, A. Mahipal, R. Mehra et al., Antitumor activity of pembrolizumab in biomarker-unselected patients with recurrent and/or metastatic head and neck squamous cell carcinoma: results from the phase Ib KEYNOTE-012 expansion cohort, J Clin Oncol, 2016.

T. Y. Seiwert, B. Burtness, R. Mehra, J. Weiss, R. Berger et al., Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial, Lancet Oncol, issue.16, pp.30066-30069, 2016.

F. Concha-benavente and R. L. Ferris, Oncogenic growth factor signaling mediating tumor escape from cellular immunity, Curr Opin Immunol, vol.45, pp.52-59, 2017.

D. Woodford, S. D. Johnson, D. Costa, A. M. Young, and M. R. , An inflammatory cytokine milieu is prominent in premalignant oral lesions, but subsides when lesions progress to squamous cell carcinoma, J Clin Cell Immunol, vol.5, issue.3, p.230, 2014.

T. Yagyuu, K. Hatakeyama, M. Imada, M. Kurihara, Y. Matsusue et al., Programmed death ligand 1 (PD-L1) expression and tumor microenvironment: implications for patients with oral precancerous lesions, Oral Oncol, vol.68, pp.36-43, 2017.

C. Badoual, S. Hans, J. Rodriguez, S. Peyrard, C. Klein et al., Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers, Clin Cancer Res, vol.12, pp.465-472, 2006.

N. Nguyen, E. Bellile, D. Thomas, J. Mchugh, L. Rozek et al., Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma, Head Neck, vol.38, pp.1074-1084, 2016.

P. Balermpas, Y. Michel, J. Wagenblast, O. Seitz, C. Weiss et al., Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer, Br J Cancer, vol.110, pp.501-509, 2014.

J. P. Foy, A. Tortereau, C. Caulin, L. Texier, V. Lavergne et al., The dynamics of gene expression changes in a mouse model of oral tumorigenesis may help refine prevention and treatment strategies in patients with oral cancer, Oncotarget, 2016.

S. D. Johnson, C. Levingston, and M. R. Young, Premalignant oral lesion cells elicit increased cytokine production and activation of T-cells, Anticancer Res, vol.36, pp.3261-3270, 2016.

S. Eikawa, M. Nishida, S. Mizukami, C. Yamazaki, E. Nakayama et al., Immune-mediated antitumor effect by type 2 diabetes drug, metformin, Proc Natl Acad Sci U S A, vol.112, pp.1809-1814, 2015.

M. D. Wilkerson and D. N. Hayes, ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking

, Bioinformatics, vol.26, pp.1572-1573, 2010.

W. Huber, V. J. Carey, R. Gentleman, S. Anders, M. Carlson et al., Orchestrating highthroughput genomic analysis with Bioconductor, Nat Methods, vol.12, pp.115-121, 2015.

R. A. Irizarry, B. Hobbs, C. F. Beazer-barclay, Y. D. Antonellis, K. J. Scherf et al., Exploration, normalization, and summaries of high density oligonucleotide array probe level data, Biostatistics, vol.4, pp.249-264, 2003.

M. Dai, P. Wang, A. D. Boyd, G. Kostov, B. Athey et al., Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data, Nucleic Acids Res, vol.33, p.175, 2005.

Y. Fan, K. Siklenka, S. K. Arora, P. Ribeiro, S. Kimmins et al., miRNet -dissecting miRNA-target interactions and functional associations through network-based visual analysis, Nucleic Acids Res, vol.44, pp.135-176, 2016.

M. Jacomy, T. Venturini, S. Heymann, M. Bastian, . Foy et al., ForceAtlas2, a continuous graph layout algorithm for handy network visualization designed for the Gephi software, PLoS One, vol.9, issue.6, pp.1496880-1496892, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01908005